This compound is primarily utilized in the development of pharmaceutical agents, particularly in the field of central nervous system (CNS) disorders. It acts as a key intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs) and other antidepressant medications. Its unique cyclopropane structure and fluorine substitution enhance its binding affinity to specific neurotransmitter receptors, making it effective in modulating serotonin levels. Additionally, it is being explored for its potential in treating anxiety disorders and chronic pain conditions due to its ability to influence neural pathways. Researchers also investigate its role in creating novel therapeutic agents targeting mood stabilization and cognitive enhancement.